These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prevalence of APOL1 Risk Variants in Afro-Descendant Patients with Chronic Kidney Disease in a Latin American Country. Duran CE; Ramírez A; Posada JG; Schweineberg J; Mesa L; Pachajoa H; Estacio M; Manzi E; Aros V; Díaz L; Garcia VH Int J Nephrol; 2019; 2019():7076326. PubMed ID: 31929905 [TBL] [Abstract][Full Text] [Related]
4. Association of Bick AG; Akwo E; Robinson-Cohen C; Lee K; Lynch J; Assimes TL; DuVall S; Edwards T; Fang H; Freiberg SM; Giri A; Huffman JE; Huang J; Hull L; Kember RL; Klarin D; Lee JS; Levin M; Miller DR; Natarajan P; Saleheen D; Shao Q; Sun YV; Tang H; Wilson O; Chang KM; Cho K; Concato J; Gaziano JM; Kathiresan S; O'Donnell CJ; Rader DJ; Tsao PS; Wilson PW; Hung AM; Damrauer SM; Circulation; 2019 Sep; 140(12):1031-1040. PubMed ID: 31337231 [TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein L1 High-Risk Genotypes and Albuminuria in Sub-Saharan African Populations. Brandenburg JT; Govender MA; Winkler CA; Boua PR; Agongo G; Fabian J; Ramsay M Clin J Am Soc Nephrol; 2022 Jun; 17(6):798-808. PubMed ID: 35577564 [TBL] [Abstract][Full Text] [Related]
6. Clinical Genetic Testing for APOL1: Are we There Yet? Young BA; Fullerton SM; Wilson JG; Cavanaugh K; Blacksher E; Spigner C; Himmelfarb J; Burke W Semin Nephrol; 2017 Nov; 37(6):552-557. PubMed ID: 29110763 [TBL] [Abstract][Full Text] [Related]
7. Association Between Chen TK; Katz R; Estrella MM; Gutierrez OM; Kramer H; Post WS; Shlipak MG; Wassel CL; Peralta CA J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29269352 [TBL] [Abstract][Full Text] [Related]
8. Genome-wide association studies suggest that APOL1-environment interactions more likely trigger kidney disease in African Americans with nondiabetic nephropathy than strong APOL1-second gene interactions. Langefeld CD; Comeau ME; Ng MCY; Guan M; Dimitrov L; Mudgal P; Spainhour MH; Julian BA; Edberg JC; Croker JA; Divers J; Hicks PJ; Bowden DW; Chan GC; Ma L; Palmer ND; Kimberly RP; Freedman BI Kidney Int; 2018 Sep; 94(3):599-607. PubMed ID: 29885931 [TBL] [Abstract][Full Text] [Related]
9. End-stage renal disease in African Americans with lupus nephritis is associated with APOL1. Freedman BI; Langefeld CD; Andringa KK; Croker JA; Williams AH; Garner NE; Birmingham DJ; Hebert LA; Hicks PJ; Segal MS; Edberg JC; Brown EE; Alarcón GS; Costenbader KH; Comeau ME; Criswell LA; Harley JB; James JA; Kamen DL; Lim SS; Merrill JT; Sivils KL; Niewold TB; Patel NM; Petri M; Ramsey-Goldman R; Reveille JD; Salmon JE; Tsao BP; Gibson KL; Byers JR; Vinnikova AK; Lea JP; Julian BA; Kimberly RP; Arthritis Rheumatol; 2014 Feb; 66(2):390-6. PubMed ID: 24504811 [TBL] [Abstract][Full Text] [Related]
10. Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression. Chen TK; Choi MJ; Kao WH; Astor BC; Scialla JJ; Appel LJ; Li L; Lipkowitz MS; Wolf M; Parekh RS; Winkler CA; Estrella MM; Crews DC Clin J Am Soc Nephrol; 2015 Dec; 10(12):2128-35. PubMed ID: 26430087 [TBL] [Abstract][Full Text] [Related]
11. APOL1 risk genotype in European steroid-resistant nephrotic syndrome and/or focal segmental glomerulosclerosis patients of different African ancestries. Gribouval O; Boyer O; Knebelmann B; Karras A; Dantal J; Fourrage C; Alibeu O; Hogan J; Dossier C; Tête MJ; Antignac C; Servais A Nephrol Dial Transplant; 2019 Nov; 34(11):1885-1893. PubMed ID: 29992269 [TBL] [Abstract][Full Text] [Related]
13. APOL1 Genetic Variants Are Associated with Serum-Oxidized Low-Density Lipoprotein Levels and Subclinical Atherosclerosis in South African CKD Patients. Hassan MO; Duarte R; Dickens C; Dix-Peek T; Naidoo S; Vachiat A; Grinter S; Manga P; Naicker S Nephron; 2020; 144(7):331-340. PubMed ID: 32526749 [TBL] [Abstract][Full Text] [Related]
14. Gutiérrez OM; Irvin MR; Chaudhary NS; Cushman M; Zakai NA; David VA; Limou S; Pamir N; Reiner AP; Naik RP; Sale MM; Safford MM; Hyacinth HI; Judd SE; Kopp JB; Winkler CA Circ Genom Precis Med; 2018 Jun; 11(6):e002098. PubMed ID: 29899045 [TBL] [Abstract][Full Text] [Related]
15. Doshi MD; Ortigosa-Goggins M; Garg AX; Li L; Poggio ED; Winkler CA; Kopp JB J Am Soc Nephrol; 2018 Apr; 29(4):1309-1316. PubMed ID: 29339549 [TBL] [Abstract][Full Text] [Related]
16. Clinical phenotype of APOL1 nephropathy in young relatives of patients with end-stage renal disease. Anyaegbu EI; Shaw AS; Hruska KA; Jain S Pediatr Nephrol; 2015 Jun; 30(6):983-9. PubMed ID: 25530085 [TBL] [Abstract][Full Text] [Related]
17. Survival Advantage of African American Dialysis Patients with End-Stage Renal Disease Causes Related to APOL1. Lertdumrongluk P; Streja E; Rhee CM; Moradi H; Chang Y; Reddy U; Tantisattamo E; Kalantar-Zadeh K; Kopp JB Cardiorenal Med; 2019; 9(4):212-221. PubMed ID: 30995638 [TBL] [Abstract][Full Text] [Related]
18. Grams ME; Surapaneni A; Ballew SH; Appel LJ; Boerwinkle E; Boulware LE; Chen TK; Coresh J; Cushman M; Divers J; Gutiérrez OM; Irvin MR; Ix JH; Kopp JB; Kuller LH; Langefeld CD; Lipkowitz MS; Mukamal KJ; Musani SK; Naik RP; Pajewski NM; Peralta CA; Tin A; Wassel CL; Wilson JG; Winkler CA; Young BA; Zakai NA; Freedman BI J Am Soc Nephrol; 2019 Oct; 30(10):2027-2036. PubMed ID: 31383730 [TBL] [Abstract][Full Text] [Related]
19. APOL1 allelic variants are associated with lower age of dialysis initiation and thereby increased dialysis vintage in African and Hispanic Americans with non-diabetic end-stage kidney disease. Tzur S; Rosset S; Skorecki K; Wasser WG Nephrol Dial Transplant; 2012 Apr; 27(4):1498-505. PubMed ID: 22357707 [TBL] [Abstract][Full Text] [Related]
20. An investigation of APOL1 risk genotypes and preterm birth in African American population cohorts. Robertson CC; Gillies CE; Putler RKB; Ng D; Reidy KJ; Crawford B; Sampson MG Nephrol Dial Transplant; 2017 Dec; 32(12):2051-2058. PubMed ID: 27638911 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]